NOTICE TO DISREGARD -- CDx Diagnostics
04. Mai 2021 11:13 ET
|
CDx Diagnostics
SUFFERN, N.Y., May 04, 2021 (GLOBE NEWSWIRE) -- We are advised by CDx Diagnostics that journalists and other readers should disregard the news release, “CDx Diagnostics Contracts with Wellmark Blue...
WATS3D Receives Medically Necessary Designation from Blue Cross Blue Shield of Kansas City
09. März 2021 11:00 ET
|
CDx Diagnostics
SUFFERN, N.Y., March 09, 2021 (GLOBE NEWSWIRE) -- WATS3D, a diagnostic platform used by physicians to detect Barrett’s esophagus (BE), pre-cancer and cancerous cells in the esophagus, has received a...
WATS3D Now Considered Medically Necessary by BlueCross BlueShield of South Carolina
26. Januar 2021 14:00 ET
|
CDx Diagnostics
SUFFERN, N.Y., Jan. 26, 2021 (GLOBE NEWSWIRE) -- WATS3D, an AI-powered diagnostic platform developed by CDx Diagnostics to identify precancerous and cancerous cells in the esophagus, is now...
Seven Medical Societies Join the ACR to Oppose Insurer Policy Limiting Access to In-Office Treatments
11. Februar 2020 15:45 ET
|
American College of Rheumatology
Atlanta, Feb. 11, 2020 (GLOBE NEWSWIRE) -- In comments submitted to BlueCross BlueShield of Tennessee, medical societies representing rheumatology, ophthalmology, dermatology, gastroenterology and...